CDC also reported increased outpatient respiratory illness visits above baseline. CDC reported a cumulative hospitalization rate of 28.1 per 100,000 by week 52
Results from a phase 2 study presented at the 2024 Alzheimers Association International Conference suggest that liraglutide, an older GLP-1 medication thats the active ingredient in Victoza and Saxenda, may help protect the brain and slow cognitive decline
For patients primarily seeking weight loss, tirzepatide may provide more dramatic results, particularly in individuals with obesity or those struggling to lose weight through diet and exercise alone
Quiets "Food Noise" Helps you feel fuller for longer 20% lower heart risk Around 20.7% body weight reduction in 72 weeks* 1 pen lasts 1 month In clinical trials, patients using Wegovy lost an average of 15% of their body weight over 68 weeks
The key factor is eating the food in an unprocessed or minimally processed state (7:40)
Body weight and BMI monthly for weight management